PUBLISHER: Daedal Research | PRODUCT CODE: 1388809
PUBLISHER: Daedal Research | PRODUCT CODE: 1388809
Global Home Infusion Therapy Market: Analysis By Product, By Application, By Route of Administration, By Region Size and Trends with Impact of COVID-19 and Forecast up to 2028
The global home infusion therapy market in 2022 was valued at US$23.55 billion. The market is expected to be worth US$38.71 billion in 2028. Home infusion therapy refers to the intravenous or subcutaneous administration of medication (drugs or biologicals) to an individual at home. It has proven to be a safe, effective, and cost-efficient alternative to hospital care. It is commonly used for gastrointestinal disorders, diabetes, cancer-related pain, cystic fibrosis, and chronic dryness, minimizing the need for frequent hospital visits and boosting drug adherence.
As chronic diseases become increasingly widespread worldwide, necessitating long-term treatment, home infusion therapy emerges as a more effective and efficient option for administration. Therefore, surging prevalence of various chronic diseases is one of the main factors that would drive the demand for home infusion therapies in the forthcoming years. The market is expected to grow at a CAGR of approx. 8.64% during the forecasted period of 2023-2028.
Market Segmentation Analysis:
By Product: The report identifies four segments on the basis of product: Infusion Pumps, Intravenous Sets, IV Cannulas, and Needleless Connectors. Among the products, Infusion Pumps segment dominated the market. Infusion pumps are commonly used for nutrient and drug delivery. The increasing preference for home-based care, driven by patient comfort and cost-effectiveness, elevates the demand for infusion pumps. In addition, technological advancements, such as portable and user-friendly designs, enhance their appeal. With a rising aging population and a growing range of treatable conditions through home infusion, infusion pumps remain indispensable, has been positively contributing to the positive growth of the segment.
By Application: The report provides the bifurcation of home infusion therapy market into seven segments on the basis of application: Anti-infective, Endocrinology, Enteral Nutrition, Specialty Pharmaceuticals, Hydration Therapy, Chemotherapy, and Others. Due to the growing incidence of infectious diseases in various nations and increased R&D activities, anti-infective segment lead the market in 2022. However, endocrinology is projected to be the fastest-growing segment owing to the growing number of conditions associated with the endocrine system. Thyroid is one of the most common disorders prevalent in the U.S., sometimes resulting in death. The American Association of Clinical Endocrinologists (AACE) is increasing its focus on implementing training programs to create awareness about the benefits of using insulin pumps. Insulin pumps are highly convenient for proper insulin delivery and help maintain the blood glucose level. Hence, growing cases of thyroid along with metabolic disorders are expected to drive the segment growth.
By Route of Administration: The report identifies three segments on the basis of route of administration: Intramuscular, Subcutaneously, and Epidural. The intramuscular segment held the largest market share in 2022, driven by growth in prevalence of chronic diseases that require medications through muscles, rise in demand for biosimilars and vaccination, and increased demand for intramuscular drug delivery due to its advantages. Furthermore, the increasing prevalence of cancer and the need for targeted drug delivery systems are also expected to drive the market.
By Region: In the report, the global home infusion therapy market is divided into five regions: North America, Europe, Asia Pacific, South & Central America, and Middle East and Africa. North America accounted for the largest share in the global home infusion therapy market in 2022. Because of the increased demand for long-term therapy for individuals with particular illnesses, increasing burden of chronic diseases such as cardiovascular disorders, neurological disorders, among other disorders, strong presence of key players in the region, the region's increased R&D and the increasing usage of new technology in infusion pumps, North America and Europe are projected to be major markets over the forecast period.
The Asia Pacific region is expected to be the fastest-growing market, because of increasing healthcare expenditure, growing consumer awareness regarding the therapy for the treatment of various chronic diseases over in-hospital procedures, increasing growing prevalence of diabetes and the expanding home healthcare sector in the region.
Market Dynamics:
Growth Drivers: The market has been growing over the past few years, due to factors such as surging prevalence of chronic diseases, lifestyle changes along with rapid urbanization, increasing diabetic population and rising inclination of patients towards home based care The prevalence of heart disease, diabetes, arthritis, Alzheimer's disease and other dementias, and cancer, major drivers of illness, disability, deaths and healthcare costs, all increase with aging. The poor compliance with treatment, poor tolerance of therapy and the presence of underlying or associated diseases makes the elder age group more vulnerable to chronic diseases. Resultantly, the aging global population contributes to increased chronic diseases, especially in older adults needing long-term care, fueling the demand for home infusion therapies. Thus, the need for home infusion therapies is growing as the global population ages, which in turn, has augmented the growth of the global home infusion therapy market.
Challenges: However, some challenges are also impeding the growth of the market such as high risk of failure associated with home infusion medical devices and limited reimbursement for homecare.
Trends: The market is projected to grow at a fast pace during the forecast period, due to various latest trends such as emerging potential in chemotherapy, rising cases of Parkinson's disease, growing occurrence of hospital-acquired infections (HAIs) and technological advancements. The immune-negotiated patients receiving infusion therapy at hospitals are at a greater risk, making home care setting the best alternative to receiving safe treatment, augmenting the preference towards home infusion therapy among patients, which is anticipated to be a vital factor driving the overall market's growth.
Impact Analysis of COVID-19 and Way Forward:
The COVID-19 pandemic has had a positive impact on the growth of the home infusion therapy market. Since the outbreak of COVID-19, the use of in-home care and home infusions has increased to free up space in hospitals and ensure patient safety. The continuous concerns over the spread of COVID-19 infection have considerably accelerated patient interest in home infusion therapy. Moreover, to fight against the disease, the immune system of the patients needed to boost. Hence, the administration of required nutrition was provided to the patients through home infusion therapies. After the pandemic, home infusions became the new standard for patients thus, supporting the market development over the forecasted period.
Competitive Landscape:
The global home infusion therapy market is highly competitive and consists of global as well as several regional players. The key players of the global home infusion therapy market are:
B. Braun (B. Braun Melsungen AG)
Becton, Dickinson and Company
Baxter International, Inc.
ICU Medical, Inc.
Fresenius Medical Care AG & Co. KGaA
Terumo Corporation
Nipro Corporation
Pfizer Inc.
Novartis AG
CSL Limited
CareCentrix, Inc.
Option Care Health Inc.
The PromptCare Companies, Inc.
Collaborations, new product development, investments connected to growing capabilities, mergers and acquisitions, partnerships and agreements, and investments in research and development are just a few of the major strategies used by the players.
Table of Contents
- 2.1 Home Infusion Therapy: An Overview
- 2.1.1 Introduction to Home Infusion Therapy
- 2.1.2 Major Advantages of Home Infusion Therapy
- 2.2 Home Infusion Therapy Segmentation: An Overview
- 2.2.1 Home Infusion Therapy Segmentation
- 3.1 Global Home Infusion Therapy Market: An Analysis
- 3.1.1 Global Home Infusion Therapy Market: An Overview
- 3.1.2 Global Home Infusion Therapy Market by Value
- 3.1.3 Global Home Infusion Therapy Market by Product
- 3.1.4 Global Home Infusion Therapy Market by Application
- 3.1.5 Global Home Infusion Therapy Market by Route of Administration
- 3.1.6 Global Home Infusion Therapy Market by Region
- 3.2 Global Home Infusion Therapy Market: Product Analysis
- 3.2.1 Global Home Infusion Therapy Market by Product: An Overview
- 3.2.2 Global Infusion Pumps Home Infusion Therapy Market by Value
- 3.2.3 Global Intravenous Sets Home Infusion Therapy Market by Value
- 3.2.4 Global IV Cannulas Home Infusion Therapy Market by Value
- 3.2.5 Global Needleless Connectors Home Infusion Therapy Market by Value
- 3.3 Global Home Infusion Therapy Market: Application Analysis
- 3.3.1 Global Home Infusion Therapy Market by Application: An Overview
- 3.3.2 Global Anti-Infective Home Infusion Therapy Market by Value
- 3.3.3 Global Endocrinology Home Infusion Therapy Market by Value
- 3.3.4 Global Enteral Nutrition Home Infusion Therapy Market by Value
- 3.3.5 Global Specialty Pharmaceuticals Home Infusion Therapy Market by Value
- 3.3.6 Global Hydration Home Infusion Therapy Market by Value
- 3.3.7 Global Home Infusion Chemotherapy Market by Value
- 3.3.8 Global Others Home Infusion Market by Value
- 3.4 Global Home Infusion Therapy Market: Route of Administration Analysis
- 3.4.1 Global Home Infusion Therapy Market by Route of Administration: An Overview
- 3.4.2 Global Intramuscular Home Infusion Therapy Market by Value
- 3.4.3 Global Subcutaneously Home Infusion Therapy Market by Value
- 3.4.4 Global Epidural Home Infusion Therapy Market by Value
- 4.1 North America Home Infusion Therapy Market: An Analysis
- 4.1.1 North America Home Infusion Therapy Market: An Overview
- 4.1.2 North America Home Infusion Therapy Market by Value
- 4.1.3 North America Home Infusion Therapy Market by Region
- 4.1.4 The US Home Infusion Therapy Market by Value
- 4.1.5 The US Home Infusion Therapy Market by Product
- 4.1.6 The US Infusion Pumps, Needleless Connectors, Intravenous Sets, & IV Cannulas Market by Value
- 4.1.7 Canada Home Infusion Therapy Market by Value
- 4.1.8 Mexico Home Infusion Therapy Market by Value
- 4.2 Europe Home Infusion Therapy Market: An Analysis
- 4.2.1 Europe Home Infusion Therapy Market: An Overview
- 4.2.2 Europe Home Infusion Therapy Market by Value
- 4.2.3 Europe Home Infusion Therapy Market by Region
- 4.2.4 Germany Home Infusion Therapy Market by Value
- 4.2.5 UK Home Infusion Therapy Market by Value
- 4.2.6 France Home Infusion Therapy Market by Value
- 4.2.7 Italy Home Infusion Therapy Market by Value
- 4.2.8 Spain Home Infusion Therapy Market by Value
- 4.2.9 Rest of Europe Home Infusion Therapy Market by Value
- 4.3 Asia Pacific Home Infusion Therapy Market: An Analysis
- 4.3.1 Asia Pacific Home Infusion Therapy Market: An Overview
- 4.3.2 Asia Pacific Home Infusion Therapy Market by Value
- 4.3.3 Asia Pacific Home Infusion Therapy Market by Region
- 4.3.4 China Home Infusion Therapy Market by Value
- 4.3.5 Japan Home Infusion Therapy Market by Value
- 4.3.6 South Korea Home Infusion Therapy Market by Value
- 4.3.7 India Home Infusion Therapy Market by Value
- 4.3.8 Rest of Asia Pacific Home Infusion Therapy Market by Value
- 4.4 South & Central America Home Infusion Therapy Market: An Analysis
- 4.4.1 South & Central America Home Infusion Therapy Market: An Overview
- 4.4.2 South & Central America Home Infusion Therapy Market by Value
- 4.5 Middle East and Africa Home Infusion Therapy Market: An Analysis
- 4.5.1 Middle East and Africa Home Infusion Therapy Market: An Overview
- 4.5.2 Middle East and Africa Home Infusion Therapy Market by Value
- 5.1 Impact of COVID on Home Infusion Therapy Market
- 5.2 Post COVID-19 Impact on Home Infusion Therapy Market
- 6.1 Growth Driver
- 6.1.1 Escalating Geriatric Population
- 6.1.2 Surging Prevalence of Chronic Diseases
- 6.1.3 Lifestyle Changes Along With Rapid Urbanization
- 6.1.4 Increasing Diabetic Population
- 6.1.5 Rising Inclination Towards Home-Based Care
- 6.2 Challenges
- 6.2.1 High Risk of Failure Associated With Home Infusion Medical Devices
- 6.2.2 Limited Reimbursement for Homecare
- 6.3 Market Trends
- 6.3.1 Emerging Potential in Chemotherapy
- 6.3.2 Rising Cases of Parkinson's Diseases
- 6.3.3 Technological Advancements
- 6.3.4 Growing Occurrence of Hospital-Acquired Infections
- 6.3.5 Economical & Clinical Benefits of Home Infusion Therapies
- 6.3.6 Expansion of Specialty Medications and Biologics
- 7.1 Global Home Infusion Therapy Market Players: Recent Developments
- 8.1 B. Braun (B. Braun Melsungen AG)
- 8.1.1 Business Overview
- 8.1.2 Sales by Division
- 8.1.3 Business Strategy
- 8.2 Becton, Dickinson and Company
- 8.2.1 Business Overview
- 8.2.2 Operating Segment
- 8.2.3 Business Strategy
- 8.3 Baxter International, Inc.
- 8.3.1 Business Overview
- 8.3.2 Operating Segments
- 8.3.3 Business Strategy
- 8.4 ICU Medical, Inc.
- 8.4.1 Business Overview
- 8.4.2 Operating Segments
- 8.4.3 Business Strategies
- 8.5 Fresenius Medical Care AG & Co. KGaA
- 8.5.1 Business Overview
- 8.5.2 Operating Segments
- 8.5.3 Business Strategy
- 8.6 Terumo Corporation
- 8.6.1 Business Overview
- 8.6.2 Operating Segments
- 8.6.3 Business Strategy
- 8.7 Nipro Corporation
- 8.7.1 Business Overview
- 8.7.2 Operating Segments
- 8.7.3 Business Strategy
- 8.8 Pfizer Inc.
- 8.8.1 Business Overview
- 8.8.2 Operating Segments
- 8.8.3 Business Strategies
- 8.9 Novartis AG
- 8.9.1 Business Overview
- 8.9.2 Operating Segments
- 8.9.3 Business Strategies
- 8.10 CSL Limited
- 8.10.1 Business Overview
- 8.10.2 Operating Segments
- 8.10.3 Business Strategies
- 8.11 CareCentrix, Inc.
- 8.11.1 Business Overview
- 8.11.2 Business Strategy
- 8.12 Option Care Health Inc.
- 8.12.1 Business Overview
- 8.12.2 Business Strategy
- 8.13 The PromptCare Companies, Inc.
- 8.13.1 Business Overview
- 8.13.2 Business Strategy
1. Executive Summary
2. Introduction
3. Global Market Analysis
4. Regional Market Analysis
5. Impact of COVID-19
6. Market Dynamics
7. Competitive Landscape
8. Company Profiling
List of Tables
- Table 1: Global Home Infusion Therapy Market: Recent Development by Key Players; 2022
List of Figures
- Figure 1: Major Advantages of Home Infusion Therapy
- Figure 2: Home Infusion Therapy Segmentation
- Figure 3: Global Home Infusion Therapy Market by Value; 2018-2022 (US$ Billion)
- Figure 4: Global Home Infusion Therapy Market by Value; 2023-2028 (US$ Billion)
- Figure 5: Global Home Infusion Therapy Market by Product; 2022 (Percentage, %)
- Figure 6: Global Home Infusion Therapy Market by Application; 2022 (Percentage, %)
- Figure 7: Global Home Infusion Therapy Market by Route of Administration; 2022 (Percentage, %)
- Figure 8: Global Home Infusion Therapy Market by Region; 2022 (Percentage, %)
- Figure 9: Global Infusion Pumps Home Infusion Therapy Market by Value; 2018-2022 (US$ Billion)
- Figure 10: Global Infusion Pumps Home Infusion Therapy Market by Value; 2023-2028 (US$ Billion)
- Figure 11: Global Intravenous Sets Home Infusion Therapy Market by Value; 2018-2022 (US$ Billion)
- Figure 12: Global Intravenous Sets Home Infusion Therapy Market by Value; 2023-2028 (US$ Billion)
- Figure 13: Global IV Cannulas Home Infusion Therapy Market by Value; 2018-2022 (US$ Billion)
- Figure 14: Global IV Cannulas Home Infusion Therapy Market by Value; 2023-2028 (US$ Billion)
- Figure 15: Global Needleless Connectors Home Infusion Therapy Market by Value; 2018-2022 (US$ Billion)
- Figure 16: Global Needleless Connectors Home Infusion Therapy Market by Value; 2023-2028 (US$ Billion)
- Figure 17: Global Anti-Infective Home Infusion Therapy Market by Value; 2018-2022 (US$ Billion)
- Figure 18: Global Anti-Infective Home Infusion Therapy Market by Value; 2023-2028 (US$ Billion)
- Figure 19: Global Endocrinology Home Infusion Therapy Market by Value; 2018-2022 (US$ Billion)
- Figure 20: Global Endocrinology Home Infusion Therapy Market by Value; 2023-2028 (US$ Billion)
- Figure 21: Global Enteral Nutrition Home Infusion Therapy Market by Value; 2018-2022 (US$ Billion)
- Figure 22: Global Enteral Nutrition Home Infusion Therapy Market by Value; 2023-2028 (US$ Billion)
- Figure 23: Global Specialty Pharmaceuticals Home Infusion Therapy Market by Value; 2018-2022 (US$ Billion)
- Figure 24: Global Specialty Pharmaceuticals Home Infusion Therapy Market by Value; 2023-2028 (US$ Billion)
- Figure 25: Global Hydration Home Infusion Therapy Market by Value; 2018-2022 (US$ Billion)
- Figure 26: Global Hydration Home Infusion Therapy Market by Value; 2023-2028 (US$ Billion)
- Figure 27: Global Home Infusion Chemotherapy Market by Value; 2018-2022 (US$ Billion)
- Figure 28: Global Home Infusion Chemotherapy Market by Value; 2023-2028 (US$ Billion)
- Figure 29: Global Others Home Infusion Market by Value; 2018-2022 (US$ Billion)
- Figure 30: Global Others Home Infusion Market by Value; 2023-2028 (US$ Billion)
- Figure 31: Global Intramuscular Home Infusion Therapy Market by Value; 2020-2022 (US$ Billion)
- Figure 32: Global Intramuscular Home Infusion Therapy Market by Value; 2023-2028 (US$ Billion)
- Figure 33: Global Subcutaneously Home Infusion Therapy Market by Value; 2018-2022 (US$ Billion)
- Figure 34: Global Subcutaneously Home Infusion Therapy Market by Value; 2023-2028 (US$ Billion)
- Figure 35: Global Epidural Home Infusion Therapy Market by Value; 2018-2022 (US$ Billion)
- Figure 36: Global Epidural Home Infusion Therapy Market by Value; 2023-2028 (US$ Billion)
- Figure 37: North America Home Infusion Therapy Market by Value; 2018-2022 (US$ Billion)
- Figure 38: North America Home Infusion Therapy Market by Value; 2023-2028 (US$ Billion)
- Figure 39: North America Home Infusion Therapy Market by Region; 2022 (Percentage, %)
- Figure 40: The US Home Infusion Therapy Market by Value; 2018-2022 (US$ Billion)
- Figure 41: The US Home Infusion Therapy Market by Value; 2023-2028 (US$ Billion)
- Figure 42: The US Home Infusion Therapy Market by Product; 2022 (Percentage, %)
- Figure 43: The US Infusion Pumps, Needleless Connectors, Intravenous Sets, & IV Cannulas Market by Value; 2018-2022 (US$ Billion)
- Figure 44: The US Infusion Pumps, Needleless Connectors, Intravenous Sets, & IV Cannulas Market by Value; 2023-2028 (US$ billion)
- Figure 45: Canada Home Infusion Therapy Market by Value; 2018-2022 (US$ Billion)
- Figure 46: Canada Home Infusion Therapy Market by Value; 2023-2028 (US$ Billion)
- Figure 47: Mexico Home Infusion Therapy Market by Value; 2018-2022 (US$ Million)
- Figure 48: Mexico Home Infusion Therapy Market by Value; 2023-2028 (US$ Billion)
- Figure 49: Europe Home Infusion Therapy Market by Value; 2018-2022 (US$ Billion)
- Figure 50: Europe Home Infusion Therapy Market by Value; 2023-2028 (US$ Billion)
- Figure 51: Europe Home Infusion Therapy Market by Region; 2022 (Percentage, %)
- Figure 52: Germany Home Infusion Therapy Market by Value; 2018-2022 (US$ Billion)
- Figure 53: Germany Home Infusion Therapy Market by Value; 2023-2028 (US$ Billion)
- Figure 54: UK Home Infusion Therapy Market by Value; 2018-2022 (US$ Billion)
- Figure 55: UK Home Infusion Therapy Market by Value; 2023-2028 (US$ Billion)
- Figure 56: France Home Infusion Therapy Market by Value; 2018-2022 (US$ Million)
- Figure 57: France Home Infusion Therapy Market by Value; 2023-2028 (US$ Million)
- Figure 58: Italy Home Infusion Therapy Market by Value; 2018-2022 (US$ Million)
- Figure 59: Italy Home Infusion Therapy Market by Value; 2023-2028 (US$ Million)
- Figure 60: Spain Home Infusion Therapy Market by Value; 2018-2022 (US$ Million)
- Figure 61: Spain Home Infusion Therapy Market by Value; 2023-2028 (US$ Million)
- Figure 62: Rest of Europe Home Infusion Therapy Market by Value; 2018-2022 (US$ Billion)
- Figure 63: Rest of Europe Home Infusion Therapy Market by Value; 2023-2028 (US$ Billion)
- Figure 64: Asia Pacific Home Infusion Therapy Market by Value; 2018-2022 (US$ Billion)
- Figure 65: Asia Pacific Home Infusion Therapy Market by Value; 2023-2028 (US$ Billion)
- Figure 66: Asia Pacific Home Infusion Therapy Market by Region; 2022 (Percentage, %)
- Figure 67: China Home Infusion Therapy Market by Value; 2018-2022 (US$ Billion)
- Figure 68: China Home Infusion Therapy Market by Value; 2023-2028 (US$ Billion)
- Figure 69: Japan Home Infusion Therapy Market by Value; 2018-2022 (US$ Million)
- Figure 70: Japan Home Infusion Therapy Market by Value; 2023-2028 (US$ Billion)
- Figure 71: South Korea Home Infusion Therapy Market by Value; 2018-2022 (US$ Million)
- Figure 72: South Korea Home Infusion Therapy Market by Value; 2023-2028 (US$ Million)
- Figure 73: India Home Infusion Therapy Market by Value; 2018-2022 (US$ Million)
- Figure 74: India Home Infusion Therapy Market by Value; 2023-2028 (US$ Million)
- Figure 75: Rest of Asia Pacific Home Infusion Therapy Market by Value; 2018-2022 (US$ Million)
- Figure 76: Rest of Asia Pacific Home Infusion Therapy Market by Value; 2023-2028 (US$ Billion)
- Figure 77: South & Central America Home Infusion Therapy Market by Value; 2018-2022 (US$ Billion)
- Figure 78: South & Central America Home Infusion Therapy Market by Value; 2023-2028 (US$ Billion)
- Figure 79: Middle East and Africa Home Infusion Therapy Market by Value; 2018-2022 (US$ Billion)
- Figure 80: Middle East and Africa Home Infusion Therapy Market by Value; 2023-2028 (US$ Billion)
- Figure 81: Global Population 65 Years and Above; 2017-2050 (Million)
- Figure 82: Global Percentage of the Population with Chronic Diseases; 2015-2030 (Percentage, %)
- Figure 83: Global Urban Population; 2016, 2021 & 2050 (Billion)
- Figure 84: Global Number of Diabetic Population; 2000-2045 (Million)
- Figure 85: The US Estimated Numbers of New Cancer Cases; 2017-2023 (Million)
- Figure 86: Global Prevalence of Parkinson's disease; 2005-2030 (Million)
- Figure 87: Braun Sales by Division; 2022 (Percentage, %)
- Figure 88: Becton, Dickinson and Company's Revenue by Segment; 2022 ( percentage, %)
- Figure 89: Baxter International Inc. Net Sales by Segment; 2022 (Percentage, %)
- Figure 90: ICU Medical, Inc. Revenue by Product Line; 2022 (Percentage, %)
- Figure 91: Fresenius Medical Care AG & Co. KGaA Revenue by Segment; 2022 (Percentage, %)
- Figure 92: Toray Industries, Inc. Revenue by Segment; 2022 (Percentage, %)
- Figure 93: Nipro Corporation Net Sales by Segment; 2022 (Percentage, %)
- Figure 94: Pfizer Inc. Revenue by Segment; 2022 (Percentage, %)
- Figure 95: Novartis AG Net Sales by Segments; 2022 (Percentage, %)
- Figure 96: CSL Limited Revenue by Segments; 2022 (Percentage, %)
